Laurus Labs Ltd

LAURUSLABS

Company Profile

  • Business description

    Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.

  • Contact

    Road No. 7, Banjara Hills
    2nd Floor, Serene Chambers
    HyderabadTG500034
    IND

    T: +91 4039804333

    https://www.lauruslabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    12,467

Stocks News & Analysis

stocks

Chart of the Week: Has gold reached bear market territory?

Investors are facing a shifting landscape.
stocks

ASX share benefiting from favourable industry trends

We anticipate further earnings growth.
stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,885.6059.900.68%
CAC 407,981.27164.332.10%
DAX 4023,298.89618.852.73%
Dow JONES (US)46,613.56272.050.59%
FTSE 10010,364.79188.341.85%
HKSE25,294.03505.892.04%
NASDAQ21,846.03255.401.18%
Nikkei 22553,739.682,675.965.24%
NZX 50 Index12,825.8786.24-0.67%
S&P 5006,579.2550.730.78%
S&P/ASX 2008,671.8053.100.62%
SSE Composite Index3,948.5556.691.46%

Market Movers